Company Filing History:
Years Active: 2021-2025
Title: Kim Ellen Schwendt: Innovator in Norovirus Vaccine Development
Introduction
Kim Ellen Schwendt is a notable inventor based in Dettenhausen, Germany. She has made significant contributions to the field of virology, particularly in the development of vaccines for Norovirus. With a total of 3 patents, her work focuses on innovative solutions for treating and preventing infections related to this virus.
Latest Patents
Schwendt's latest patents include groundbreaking inventions aimed at combating Norovirus. One patent is titled "Compositions comprising a norovirus nucleic acid and methods of use thereof." This invention is directed to an artificial nucleic acid and polypeptides that are suitable for use in the treatment or prophylaxis of Norovirus infections. It specifically concerns a Norovirus vaccine and includes methods for treating or preventing related disorders. The invention also encompasses a kit comprising the artificial nucleic acid, polypeptides, compositions, and vaccines.
Another significant patent is "Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof." Similar to her previous work, this invention focuses on artificial nucleic acids and polypeptides for treating Norovirus infections. It also includes methods for preventing related diseases and a kit of parts that comprises the necessary components for effective treatment.
Career Highlights
Throughout her career, Kim Ellen Schwendt has worked with prominent companies in the biotechnology sector, including CureVac AG and CureVac SE. Her experience in these organizations has allowed her to contribute to cutting-edge research and development in vaccine technology.
Collaborations
Schwendt has collaborated with notable colleagues, including Susanne Rauch and Benjamin Petsch. These partnerships have further enhanced her research efforts and have been instrumental in advancing her innovative projects.
Conclusion
Kim Ellen Schwendt is a pioneering inventor whose work in Norovirus vaccine development is making a significant impact in the field of virology. Her patents reflect her commitment to finding effective solutions for viral infections, and her collaborations with esteemed colleagues highlight the importance of teamwork in scientific advancements.